CU Alzheimer's and Cognition Center

Black lives matter. The researchers, clinicians, and staff of the University of Colorado Alzheimer’s and Cognition Center are strongly committed to addressing the unacceptable racial disparities in dementia burden, clinical care access, and research priorities. We vigorously condemn racism in all its forms, including systemic inequities that contribute to Black people being up to twice as likely to develop Alzheimer’s disease as white people. We believe that it is not enough to hold these beliefs – we must speak out, and more importantly, we must enact change. We are developing a dedicated action plan to take meaningful steps towards these goals. We look forward to sharing these plans with our community in the near future, and we will actively listen to your feedback. Healthy brain aging starts here. For all.

Register for the Dementia Researcher Salon tomorrow, January 8th, for a webinar on inclusivity in dementia research! Dr. Ece Bayram and Karah Alexander, MPH, will discuss the ethical and methodological challenges of engaging under-represented voices in research—and how inclusivity enhances our understanding of dementia. https://lnkd.in/gcKdR4yS

It is interesting to see that donepezil, a drug commonly used to treat memory problems in Alzheimer’s disease, may also improve verbal memory in individuals with traumatic brain injury (TBI). This research, led by our Neurology colleague David Arciniegas, MD, published in the Journal of Neuropsychiatry and Clinical Neurosciences, highlights new possibilities for treatment.

We are proud to have been a site for the Phase 2 study of CT1812 in individuals with dementia with Lewy bodies (DLB) and grateful for the dedication of all of our participants! This study recently reported positive results, highlighting potential advances in DLB research and treatment. Learn more about the study findings by reading the Cognition Therapeutics press release.

Our latest newsletter came out last week! This issue features reflections from individuals living with Alzheimer’s, staff highlights, a Provider Spotlight on Mary O’Hara, LCSW, details about 2025 support groups, and a genetics overview. Check it out: https://lnkd.in/gefpJcTn Interested in subscribing? - head to this link: https://lnkd.in/gHKSEPZY

We’re proud to see one of our own featured in this Neurology Today article on the challenges and potential of blood-based biomarkers for Alzheimer’s disease!

We're thrilled to congratulate Dr. Brice McConnell on receiving an R01 grant from the NIH National Institute on Aging (NIA)! Congratulations also to Dr. Brianne Bettcher, a key co-investigator on this project. Dr. McConnell's research "Quantifying the Integrity of Sleep-Dependent Memory Processing in Pathological Aging and Alzheimer's Disease: Toward Inexpensive Electroencephalographic Wearable Applications" aims to change how we monitor brain health by collecting simple sleep EEG recordings from user-friendly wearable devices. #CUAnschutzTogether #AlzheimersResearch

Do you know someone with Alzheimer's disease? This research study may be for you Check your eligibility here: https://lnkd.in/gfayuQ4F

Don't forget! Our "Other Dementias" webinar is happening TOMORROW! When: Wednesday, December 4, 2024 Time: 12:00 PM - 1:30 PM (MDT) Where: Virtual Join us to gain valuable insights on white matter dementia, frontotemporal dementia, and LATE with expert speakers from the CU Alzheimer's and Cognition Center.